Evaluation the serum levels of T3, T4, TSH, Thyroglobulin and Galactin-3 in patients with benign and malignant thyroid tumors. (2022). Journal of Pharmaceutical Negative Results, 13(3), 559-571. https://doi.org/10.47750/pnr.2022.13.03.085